XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.1
BASIC AND DILUTED NET LOSS PER SHARE
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET LOSS PER SHARE

NOTE 10 - BASIC AND DILUTED NET LOSS PER SHARE

 

The basic and diluted net loss per share and weighted average number of shares of common stock used in the calculation of basic and diluted net loss per share were presented in the consolidated statements of comprehensive loss for the years ended December 31, 2021 and 2020.

 

Due to the net loss to common stockholders in each of the periods presented above, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. As of December 31, 2021 and 2020, potentially dilutive securities excluded from the diluted loss per share calculation are as follows:

 

 

MICROBOT MEDICAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

(Except share and per share data)

 

   For the Years Ended
December 31,		 
   2021   2020 
         
Series A and B warrants   2,953    2,953 
Warrant to underwriters 12.2019   175,889    175,889 
Outstanding options to purchase common stock   997,148    575,722